| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -96,512,193 | -83,618,591 |
| Depreciation and amortization | 975,275 | - |
| Loss on disposal of property and equipment | 0 | 0 |
| Non cash interest income on note receivable | 1,189,144 | 363,798 |
| Stock-based compensation | 10,803,186 | 6,319,378 |
| Convertible note payable for non-cash issuance costs | 0 | 0 |
| Shares issued for non-cash consultant expense | 673,497 | 673,497 |
| Change in fair value of share liability | -200,138 | -129,269 |
| Change in fair value of convertible notes payable | -64,542,295 | -64,715,131 |
| Change in right-of-use lease asset | 450,453 | 267,952 |
| Depreciation | - | 678,959 |
| Non-cash lease income | 44,540 | 22,064 |
| Change in deferred taxes | 33,175 | 285 |
| Accounts receivable | -1,103,993 | -89,048 |
| Receivable from noncontrolling interest | -28,706 | -28,353 |
| Inventories | 696,759 | 946,052 |
| Prepaid expenses and other current assets | 1,190,095 | -1,318,444 |
| Other noncurrent assets | -1,186,095 | -103,204 |
| Accounts payable | 37,633 | 1,106,878 |
| Accrued expenses | 887,712 | -507,883 |
| Operating lease liabilities | -448,320 | -275,614 |
| Other current liabilities | -770,065 | -767,707 |
| Net cash used in operating activities | -19,928,958 | -11,071,311 |
| Purchases of property and equipment | 7,255,776 | 4,107,564 |
| Purchase of equity investments | 5,000,000 | - |
| Cash received for acquisition of business, net of cash paid | -6,643,797 | - |
| Cash advance in exchanges for note receivable | 30,000,000 | 30,000,000 |
| Net cash used in investing activities | -35,611,979 | -34,107,564 |
| Payment of notes payable | - | 409,696 |
| Proceeds from bank loans | - | 47,045 |
| Proceeds from issuance of common stock | 110,000,000 | 50,000,000 |
| Payment of principal portion of bank loans | - | 392,263 |
| Payment of common stock issuance costs | 6,932,580 | 3,238,630 |
| Proceeds from exercise of warrants | 4,915,312 | 4,915,312 |
| Due to related parties | 590,195 | - |
| Proceeds from noncontrolling interest in vie | 0 | 0 |
| Proceeds from collection of receivable from noncontrolling interest in vie | 0 | 0 |
| Distribution to noncontrolling interest in vie | 403,581 | 79,310 |
| Proceeds from issuance of convertible notes payable | 0 | 0 |
| Proceeds from issuance of debt | 2,804,466 | - |
| Payment of principal portion of debt | 3,384,553 | - |
| Payment of principal portion of finance leases | 104,447 | 61,831 |
| Net cash provided by financing activities | 107,484,812 | 50,780,627 |
| Net change in cash and cash equivalents | 51,943,875 | 5,601,752 |
| Effect of exchange rate changes on cash | 108,233 | - |
| Cash and cash equivalents at beginning of period | 61,890,048 | - |
| Cash and cash equivalents at end of period | 113,942,156 | - |
ASP Isotopes Inc. (ASPI)
ASP Isotopes Inc. (ASPI)